Diagnostic Panels and Testing

PCG logo.PNG

 products

comprehensive testing and greater diagnostics

PCG Molecular's menu expansion is proceeding at a very fast clip, and we have a robust set of tests showing strong progress that will increase our addressable opportunity. We offer advanced diagnostic testing for physicians, clinicians, health care facilities, and point of care options for patients. Our goal is to provide practitioners with pliable business models, affordable tests for their patients, and easy to understand results and post-treatment recommendations. We are a  preventive care diagnostic company driven to change the approach to health, from reactive care to proactive care. We are vested in the research and development of genetic, molecular screenings that detect health threats early, are non-invasive, and easy to administer to the patient.

Oral One PAP™
genetic molecular oral test

The Oral One PAP™ is a comprehensive screening of a range of infectious diseases particularly oral infections that are transmitted orally.

Oral One PAP 1.0 - Infectious Disease Panel

AdobeStock_347294369_edited.png

Cysto One PAP 1.0 - Urinary & Infectious Disease Panel

Screen Shot 2021-11-08 at 5.30_edited.pn
Screen Shot 2021-11-02 at 12.36.12 PM.png

The Cysto One PAP™ is a molecular test to screen and diagnose low and high grade urinary bladder malignancies as well as urinary tract infections and sexually transmitted diseases.

Bella One PAP 1.0 - Infectious Disease Panel

Screen Shot 2021-11-02 at 12.35.42 PM.png

The Bella One PAP™ is the first FDA-approved test to screen not only for 14 high-risk strains of HPV, but also for other sexually transmitted infections that pose a threat to women’s health.

AdobeStock_443554927_edited.png

The PCG Molecular® Respiratory 2.1 (RP2.1) Panel

AdobeStock_463622056_edited.png

Anal One PAP 1.0 - Cancer Test

AdobeStock_111986085_edited.png

Respiratory Panel

Screen Shot 2021-11-08 at 4.59.16 PM.png

SARS-CoV-2 is a top concern for patients and clinicians, but several respiratory pathogens can cause nearly indistinguishable symptoms. The FDA De Novo authorized PCG Molecular RP2.1 Panel is a frontline test to help clinicians quickly diagnose respiratory infections, including COVID-19, influenza, RSV, and many others.

Anal One PAP 1.0 - Cancer Test

Screen Shot 2021-11-08 at 5_edited_edite
Screen Shot 2021-11-02 at 12.36.04 PM.png

The Anal One PAP™ not only shows whether you have anal cancer, but also if your in a higher risk category to contract it. It’s an innovative genetic test that screens for anal cancer and its risk factors in three ways.

The PCG Molecular® FilmArray® Gastrointestinal Panel

Gastrointestinal Panel

Screen Shot 2021-11-08 at 4.59.16 PM.png

The PCG Molecular GI Panel tests stool specimens for common pathogens associated with gastroenteritis. Quickly identifying the correct pathogen can ensure appropriate treatment, improve patient management, and help detect infectious gastroenteritis which can lead to severe illness or death.

AdobeStock_302423130_edited.png